Navigo Proteins GmbH
Records under this name other than the patents Navigo Proteins GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
Showing 1 to 5 of 5 · Back to Navigo Proteins GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,838,629 | Ubiquitin or Gamma-Crystalline Conjugates for Use in Therapy, Diagnosis and Chromatography Term ended Term ended Oct 28, 2026 · High confidence | Term ended | Term ended Oct 28, 2026 | High confidence |
| US 8,790,895 | Generation of artificial binding proteins on the basis of ubiquitin proteins Lapsed on the fee record Ended Jul 29, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 29, 2026 | Medium confidence |
| US 8,592,179 | Artificial binding proteins based on a modified alpha helical region of ubiquitin Lapsed on the fee record Ended Nov 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 26, 2025 | From the USPTO record |
| US 8,791,238 | Artificial Binding Proteins Based on Ubiquitin Term ended Ended no later than Jun 30, 2025 · Medium confidence | Term ended | Ended no later than Jun 30, 2025 | Medium confidence |
| US 8,629,088 | Mixture of at least two fusion proteins, the production thereof and the use of the same Lapsed on the fee record Ended Jan 14, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2022 | From the USPTO record |